PharmaShots | Incisive News in 3 Shots

Subscribe Now

METex14

Merck KGaA's Tepmetko (tepotinib) Receives the US FDA's Approval for Patients with Metastatic NSCLC with METex14 Skipping Alterations

Merck KGaA's Tepmetko (tepotinib) Receives the US FDA's Approval for Patients with Metastatic NSCLC with METex14 Skipping Alterati...

February 4, 2021

Novartis and Incyte's Tabrecta (capmatinib- INC280) Receives the US FDA's Approval for Metastatic Non-Small Cell Lung Cancer with METex14

Novartis and Incyte's Tabrecta (capmatinib- INC280) Receives the US FDA's Approval for Metastatic Non-Small Cell Lung Cancer with...

May 7, 2020

Novartis' Capmatinib (INC280) Receives FDA's Priority Review for METex14 Mutated Advanced Non-Small Cell Lung Cancer

Novartis' Capmatinib (INC280) Receives FDA's Priority Review for METex14 Mutated Advanced Non-Small Cell Lung Cancer

February 11, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us